PMID: 6979049Mar 1, 1982Paper

Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity

Proceedings of the National Academy of Sciences of the United States of America
H CarpA Janoff

Abstract

The elastase inhibitory capacity per mg of alpha 1-proteinase inhibitor (alpha 1 PI) was measured in the bronchoalveolar lavage (BAL) fluid from 26 healthy smokers and 24 nonsmokers. Activity was decreased by 40% in smokers' BAL fluid compared to nonsmokers. This effect was demonstrable by using human neutrophil elastase as well as porcine pancreatic elastase as test enzyme (elastase, EC 3.4.21.11) and was reproducible when selected individuals in each group underwent lavage on repeated occasions. In contrast, the functional activity of alpha 1-antichymotrypsin was not decreased in smokers' BAL fluid. Crossed antigen-antibody electrophoresis confirmed that inactivation of alpha 1 PI was responsible for the decrease in the elastase inhibitory capacity of smokers' BAL fluid. alpha 1 PI purified from smokers' BAL fluids contained methionine sulfoxide (4 mol/mol of inactive alpha 1 PI), whereas alpha 1 PI from nonsmokers' BAL fluid did not. Smokers' alpha 1 PI was indistinguishable from nonsmokers' alpha 1 PI on the basis of electrophoretic mobility, molecular weight, and immunoreactivity. Thus, oxidation of methionine residues in lung alpha 1 PI is associated with cigarette smoking. Because chemical oxidation of alpha 1 PI in vitr...Continue Reading

References

Dec 26, 1978·Biochemistry·J TravisJ Bowen
May 28, 1979·Biochemical and Biophysical Research Communications·N R MathesonJ Travis
Oct 7, 1975·Biochemistry·Y ShechterA Patchornik
Apr 20, 1972·The New England Journal of Medicine·O AuerbachC Benante
Oct 16, 1980·Biochemical and Biophysical Research Communications·P S Wong, J Travis
Oct 1, 1980·European Journal of Clinical Investigation·K OhlssonH Tegner
Dec 1, 1980·The Journal of Experimental Medicine·M J BandaZ Werb

❮ Previous
Next ❯

Citations

Jun 1, 1996·Inflammation·M E HanleyJ E Repine
Jun 15, 2006·Amino Acids·E KarnaukhovaB Golding
Jun 4, 2010·Pathology Oncology Research : POR·Aleksandra TopicDragica Radojkovic
Aug 31, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·C BoudierJ G Bieth
Jan 1, 1985·The International Journal of Biochemistry·S D Pearson, J C Gan
Sep 15, 1996·Journal of the Neurological Sciences·P GaetaniR R Baena
Apr 1, 1995·Respiration Physiology·K FujimotoK Sugane
Jan 1, 1987·Pharmacology & Therapeutics·V Bocci
Jan 1, 1995·Biochimie·M Martínez-Cayuela
Jan 1, 1995·Free Radical Biology & Medicine·W Vogt
Jan 1, 1996·Free Radical Biology & Medicine·I Rahman, W MacNee
Dec 19, 2003·Free Radical Biology & Medicine·David E RichardsonJodie V Johnson
Jun 16, 2005·Mechanisms of Ageing and Development·Maria Cristina RuizReinald Pamplona
Dec 6, 1997·European Journal of Pharmacology·Y ShinguhT Ono
May 20, 1998·European Journal of Pharmacology·Y ShinguhT Ono
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E J Campbell
May 9, 2006·Antioxidants & Redox Signaling·Alberto SanzGustavo Barja
Feb 15, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Noriyuki HiramaIsao Kubota
May 28, 1993·Annals of the New York Academy of Sciences·W A Pryor, K Stone
Nov 17, 2010·Pharmacological Reviews·Brice KorkmazFrancis Gauthier
Nov 26, 2011·Science·Ruei-Jiun HungJonathan R Terman
Apr 1, 1995·Journal of Clinical Pathology·M B LeonardI MacFarlane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.